Clinical-histopathologic concordance of tumors of the nervous system at the Manuel Velasco Suárez National Institute of Neurology and Neurosurgery in Mexico City

Archives of Pathology and Laboratory Medicine

Volumn 127, Issue 2, 2003, Pages 187-192

  Velásquez Pérez, Leora ^a   Jiménez Marcial, María Esther ^a  

^a NATIONAL INSTITUTE OF NEUROLOGY AND NEUROSURGERY   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CHILD; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MENINGIOMA; MEXICO; NERVOUS SYSTEM TUMOR; NEUROEPITHELIOMA; SELLA TURCICA TUMOR;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; DIAGNOSIS, DIFFERENTIAL; DIAGNOSTIC ERRORS; FEMALE; HUMANS; MALE; MEXICO; MIDDLE AGED; NERVOUS SYSTEM NEOPLASMS; QUALITY OF HEALTH CARE; WORLD HEALTH ORGANIZATION;

EID: 0037324208     PISSN: 00039985     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Fajardo A, Yamamoto LT, Garduño J, Hernández DM, Martínez MC. Consistencia y validez de una medición en la investigación clínica pediátrica: definición, evaluación y su interpretación. Bol Med Hosp Infant Mex. 1991;48:367-381.
2. Ginsberg LE, Fuller GN, Hashmi M, Leeds NE, Schomer DF. The significance of lack of MR contrast enhancement of supratentorial brain tumors in adults: histopathological evaluation of a series. Surg Neurol. 1998;49:436-440.
3. Valdez E, Arroyo E, Landero L. Concordancia entre el diagnóstico clínico y el patológico por necropsias. Salud Publica Mex. 1998;40:32-37.
4. Kassirer JP. Sounding board, our stubborn quest for diagnostic certainty. N Engl J Med. 1989;320:1489-1491.
5. Kassirer JP. Diagnostic reasoning. Ann Intern Med. 1989;110:893-900.
6. Barrows HS, Bennett K. The diagnostic (problem solving) skill of the neurologist: experimental studies and their implications for neurologic training. Arch Neurol. 1972;26:273-277.
7. Pauker SG, Kassirer JP. Therapeutic decision making. N Engl J Med. 1980;302:1109-1117.
8. Antigüedad A, Bárcena J, Pérez M, Aldape J, Hurtado P, Zarranz JJ. Actividad asistencial de los facultativos especialistas de área en Neurología: experiencia en Vizcaya. Neurologia. 1995;10:324-329.
9. DeAngelis LM. Brain tumors. N Engl J Med. 2001;344:114-123.
10. Forsyth PA, Posner JB. Headaches in patients with brain tumors: a study of 111 patients. Neurology. 1993;43:1678-1683.
11. Kleihues P, Louis DN, Schethauer BW, et al. The WHO classification of tumors of the nervous system. J Neuropathol Exp Neurol. 2002;61:215-225.
12. Thompson WD, Walter SD. A reappraisal of the Kappa coefficient. J Clin Epidemiol. 1988;41:949-958.
13. Feinstein AR. Statistical indexes of association. In: Clinical Epidemiology: The Architecture of Clinical Research. Philadelphia, Pa: WB Saunders; 1985:185-187.
14. Landis RJ, Koch GG. The measurement of observer agreement for categorical data. Biometrics. 1977;33:159-174.
15. Zarbo RJ, Baker PB, Howanitz PJ. The autopsy as a performance measurement tool: diagnostic discrepancies and unresolved clinical questions. Arch Pathol Lab Med. 1999;123:191-198.
16. Werner MH, Phuphanich S, Lyman GH. The increasing incidence of malignant gliomas and primary central nervous system lymphoma in the elderly. Cancer. 1995;76:1634-1642.
17. Anderson NH, Shanks JH, McCluggage GWG, Toner PG. Necropsies in clinical audit. J Clin Pathol. 1989;42:897-901.
18. Angeles AA, Quintanilla ML, Muñoz FL, Espinoza VB, Victoria PP. Concordancia diagnóstica clínico-patológica en 429 autopsias del Instituto Nacional de la Nutrición Salvador Zubirán. Rev Invest Clin. 1992;44:13-20.
19. Britton M. Diagnostic errors discovered at autopsy. Acta Med Scand. 1974;196:203-210.
20. Goldman L, Sayson R, Robbins S, Cohn LH, Bettmann M, Weisberg M. The value of the autopsy in three medical eras. N Engl J Med. 1983;308:1000-1005.
21. Cameron HM, McGoogan E. A prospective study of 152 hospital autopsies, I: inaccuracies in death certification. J Pathol. 1981;133:273-283.
22. Kleihues P, Ohgaki H. Primary and secondary glioblastomas: from concept to clinical diagnosis. Neurooncology. 1999;1:44-45.
23. Jung V, Romeike BFM, Henn W, et al. Evidence of focal genetic microheterogeneity in glioblastoma multiforme by area-specific CGH on microdissected tumor cells. J Neuropathol Exp Neurol. 1999;58:993-999.
24. Levin VA, Wara WM, Davis RL, et al. Phase III comparison of BCNU and the combination of procarbazine, CCNU, and vincristine administered after radiotherapy with hydroxyurea for malignant gliomas. J Neurosurg. 1985;63:218-223.
25. Eberhart CG, Morrison A, Gyure KA, Frazier J, Smialek JE, Troncoso JC. Decreasing incidence of sudden death due to undiagnosed primary central nervous system tumors. Arch Pathol Lab Med. 2001;125:1024-1030.
26. Modan B, Wagener DK, Feldman JJ, Rosenberg HM, Feinleib M. Increased mortality from brain tumors: a combined outcome of diagnostic technology and changes in attitude toward the elderly. Am J Epidemiol. 1992;135:1349-1357.
27. Aguirre GJ. La autopsia: ¿un procedimiento que ha pasado de moda? Gac Med Mex. 1988;124:339-357.